Nyctalopin Antikörper (AA 139-189)
Kurzübersicht für Nyctalopin Antikörper (AA 139-189) (ABIN8123495)
Target
Alle Nyctalopin (NYX) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 139-189
-
Verwendungszweck
- NYX Antibody
-
Spezifität
- This antibody detects endogenous levels of NYX at Human/Mouse
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from human NYX AA range: 139-189
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB 1:500-2000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C/1 year
-
Haltbarkeit
- 12 months
-
-
- Nyctalopin (NYX)
-
Andere Bezeichnung
- NYX
-
Hintergrund
-
Background: The product of this gene belongs to the small leucine-rich proteoglycan (SLRP) family of proteins. Defects in this gene are the cause of congenital stationary night blindness type 1 (CSNB1), also called X-linked congenital stationary night blindness (XLCSNB). CSNB1 is a rare inherited retinal disorder characterized by impaired scotopic vision, myopia, hyperopia, nystagmus and reduced visual acuity. The role of other SLRP proteins suggests that mutations in this gene disrupt developing retinal interconnections involving the ON-bipolar cells, leading to the visual losses seen in patients with complete CSNB. [provided by RefSeq, Oct 2008],
Gene Name: NYX CLRP
Protein Name: NYX
-
Gen-ID
- 60506
-
UniProt
- Q9GZU5
Target
-